Post-Polypectomy Colorectal Cancers Common Before Follow-Up
SAN DIEGO — The majority of colorectal cancers (CRCs) that emerge following a negative colonoscopy and polypectomy occur prior to ...
Adult Sugammadex Dosing Safe, Effective in Kids Aged < 2
TOPLINE:Sugammadex doses of 2 and 4 mg/kg, recommended for adults and children aged 2 years or older, were safe and ...
Helping on the farm in Surrey is reaping mental health rewards
Julia GregoryReporter BBC SurreyReporting fromSurrey HillsJulia Gregory/BBCYoung people have a chance to meet farm animalsOn a farm nestled in the ...
Three GPs give their views on assisted dying
Catherine BurnsHealth correspondentVicki LoaderHealth producerBBCMore than 1,000 GPs in England have shared their views about the assisted dying bill with ...
Sedentary Time Tied to Brain Volume, Worse Cognition in Older Adults
(MedPage Today) -- More time spent sitting or lying down was linked with neurodegeneration and worse cognitive scores in older ...
Expect More Downside Risk in Medicare’s Payment Models, CMS Official Says
(MedPage Today) -- Physicians should expect to see more Medicare alternative payment models that involve downside risk, Abe Sutton, JD, ...
Better Survival in BRCA-Mutated Breast Cancer With Neoadjuvant Olaparib-Chemo Combo
(MedPage Today) -- Overall survival (OS) in BRCA-mutated breast cancer improved significantly with the addition of olaparib (Lynparza) to neoadjuvant ...
Doctors, Other Healthcare Workers Strike in Washington State
(MedPage Today) -- Physicians and other healthcare workers at PeaceHealth facilities in Washington state are on strike this week, calling ...
HIV Drugs and Alzheimer’s; Duchenne Drug Shows Benefit; PFAS and Cognitive Changes
(MedPage Today) -- Nucleoside reverse transcriptase inhibitors -- antiretroviral drugs approved to treat HIV and hepatitis B -- were associated ...
Low LDL and Bleeding Risk; Improved HoFH Life Expectancy; ANGPTL4 mAb Progress
(MedPage Today) -- Low LDL cholesterol was associated with an increased risk of bleeding in patients receiving anticoagulation for venous ...
CVS Drops Obesity Drug; Once-Weekly Growth Hormone; WeightWatchers’ Bankruptcy
(MedPage Today) -- Many patients may have to switch obesity drugs now that CVS Caremark opted to stop offering tirzepatide ...
The FBI is getting new technology to see through walls
FBI headquarters in Washington DCShutterstock/Bob Korn The US Federal Bureau of Investigation (FBI) plans to buy radar technology that can ...
FDA, RFK Jr. Aim to Remove Ingestible Fluoride Products Used to Protect Kids’ Teeth
(MedPage Today) -- U.S. health regulators announced plans Tuesday to phase out ingestible fluoride-containing supplements sometimes used to strengthen children's ...
Would You Recognize the Signs of Trafficking in a Patient?
(MedPage Today) -- A recent episode of HBO Max's "The Pitt" brought human trafficking into primetime television, showcasing a young ...
Late Abortions Are Rare. The U.S. Just Lost a Clinic That Performed Them Since 1973.
(MedPage Today) -- To fellow travelers, Hannah Brehm likely looked like she was taking a belated babymoon well into her ...
Polarized and Politicized: Can We Find Middle Ground in Youth Gender Care?
(MedPage Today) -- A recent HHS report questioning the origins of gender dysphoria, rejecting medical interventions for transgender adolescents, and ...
Aeronutrients: The wild idea that we all get nutrition from the air that we breathe
Could aeronutrients explain the benefits of being in nature?Daniel Ernst/Stills Around 10 years ago, British tabloid newspaper The Sun ran a ...
Global Progress Continues on Reducing Rotavirus Burden, With Caveats
(MedPage Today) -- The introduction of the rotavirus vaccine has had a profound impact on global pediatric deaths from acute ...
USPSTF Reaffirms Universal Syphilis Screening in Pregnancy
(MedPage Today) -- The U.S. Preventive Services Task Force (USPSTF) renewed its recommendation for early and universal screening for syphilis ...
Pfizer Confirms: Leading JAK Inhibitor Often Comes With Weight Gain
(MedPage Today) -- Patients taking tofacitinib (Xeljanz) in the drug's late-stage and post-marketing studies were more likely than those on ...
